Telemedicine interventions consistently produced modest but statistically significant reductions in systolic blood pressure compared to usual care in adults with hypertension.
Do telemedicine interventions reduce blood pressure in adults with hypertension?
Telemedicine interventions provide modest but clinically meaningful reductions in systolic blood pressure for hypertension management, though equitable impact requires addressing digital literacy, engagement, and reimbursement barriers.
Hypertension remains insufficiently controlled in many adult populations despite established pharmacological therapies, prompting increasing adoption of telemedicine and digital health interventions in chronic disease management (Raquib et al., 2025; Ali et al., 2024). Objective: This structured review aimed to synthesize current evidence on the clinical effectiveness of telemedicine interventions in hypertension management, categorize technological innovations, identify social and implementation barriers, and evaluate impacts on patient engagement and quality of life. Methods: This study was conducted as a structured evidence synthesis integrating findings from peer-reviewed publications published between 2020 and 2026, including systematic reviews, meta-analyses, randomized controlled trials, scoping reviews, usability studies, and implementation analyses addressing telemedicine and digital health interventions in adult hypertension management (Li et al., 2020; Yang et al., 2026; Sakima et al., 2025; Khalid et al., 2023). Publications were selected based on their relevance to clinical effectiveness, technological characteristics, implementation barriers, patient engagement, and patient-reported outcomes. Protocol Registration: This study was not prospectively registered, as it was designed as a structured integrative review rather than a PRISMA-based systematic review involving a de novo database search. Results: Across multiple meta-analyses and randomized trials, telemedicine interventions were associated with modest but statistically significant reductions in systolic blood pressure, with greater effects observed in hybrid models integrating remote monitoring and structured professional support (Kassavou et al., 2022; Lakshminarayan et al., 2026). However, heterogeneity in intervention design, engagement variability, digital literacy barriers, and reimbursement constraints influenced effectiveness across populations (Khoong et al., 2021; Buis et al., 2024; Shanab et al., 2025). Evidence regarding long-term quality-of-life outcomes remains limited and inconsistently reported (Meda et al., 2024; Raquib et al., 2025). Conclusions: Telemedicine represents a promising yet context-dependent model for hypertension management. Achieving sustainable and equitable impact requires integration within multidisciplinary care frameworks.
Kańska et al. (Mon,) conducted a review in Hypertension. Telemedicine and digital health interventions vs. Usual care was evaluated on Systolic blood pressure reduction. Telemedicine interventions consistently produced modest but statistically significant reductions in systolic blood pressure compared to usual care in adults with hypertension.